Mandatory notice of shareholding

Reference is made to IDEX Biometrics ASA's disclosure on 4 December 2025 of a private placement of 7,333,333 shares at NOK 3.00 per share, split into two tranches.The issuance of Tranche 2 shares was approved by the Company's EGM on 20 January 2026.

Tranche 2 of the private placement includes 1,642,363 shares, and Altea AS has subscribed for 975,695 shares in Tranche 2, and thereby passes the 10% threshold. After completion of Tranche 2, Altea will hold 7,001,622 shares in IDEX, which represent 10,77% of the shares and voting rights in IDEX.

ContactsAnders Storbråten, CEO and CFO, Tel: +47 416 38 582E-mail: [email protected]

About UsIDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.

IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments. For more information, visit www.idexbiometrics.com

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-26 20:00 CET.

AttachmentsMandatory notice of shareholding